# Mindray to acquire 75% stake in DiaSys Diagnostic Systems for €115M

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. has agreed to acquire 75% equity interest in DiaSys Diagnostic Systems GmbH from Gorka Holding GmbH for a preliminary cash consideration of approximately €115 million. The acquisition will support Mindray's IVD business expansion.

- Type: Acquisition
- Announced: 2023-07-31
- Where: Holzheim, Germany, Germany
- Value: $126.5M (115.0M EUR)
- Status: announced
- Products: in vitro diagnostics, IVD controls and calibrators
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Shenzhen Mindray Bio-Medical Electronics](https://endata.com/companies/71744.md)
- [Mindray Bio-Medical Electronics](https://endata.com/companies/66451.md) (acquirer)
- [DiaSys Diagnostic Systems](https://endata.com/companies/71733.md) (target)
- [Gorka Holding](https://endata.com/companies/71734.md) (partner)

## Sources

- [g-medtech.com](https://g-medtech.com/news/mindray-to-acquire-75-stake-in-diasys-diagnostic-systems-for-e115-million/), 2023-07-31: "Through this acquisition, Mindray will effectively improve its overseas supply chain platform and support the penetration of our IVD business in the medium to large customer segments."
- [www2.yicaiglobal.com](https://www2.yicaiglobal.com/news/chinas-mindray-bio-medical-to-buy-controlling-stake-raise-capital-in-diasys-diagnostic-for-usd1593-million), 2023-08-01: "Mindray Medical Netherlands inked two deals with DiaSys Diagnostic's shareholder Gorka Holding on July 29 to buy 75 percent of the in-vitro diagnostics products and solutions provider for EUR115 million in cash."
- [caivd-org.cn](https://www.caivd-org.cn/en/m/article.asp?id=2470), 2023-08-01: "Mindray has agreed to acquire 75% equity interest in DiaSys Diagnostic Systems GmbH from Gorka Holding GmbH, through Mindray Medical Netherlands B.V."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.